The European Medicines Agency (EMA) is a decentralized agency of the European Union responsible for the scientific evaluation, supervision, and safety monitoring of medicines in the EU. The EMA's mission is to ensure that all medicines available on the EU market are safe, effective, and of high quality. The agency plays a crucial role in the development and approval of new treatments, including those that involve nanotechnology.
